Drugs Made In America Acquisition Corp
NASDAQ:DMAA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
|
US |
|
Decibel Cannabis Company Inc
XTSX:DB
|
CA |
|
B
|
BYD Co Ltd
XMUN:BY6A
|
CN |
|
I
|
Irving Resources Inc
CNSX:IRV
|
CA |
|
Stargaze Entertainment Group Inc
OTC:STGZ
|
US |
|
Ensurge Micropower ASA
F:B7X
|
NO |
|
Euronet Worldwide Inc
NASDAQ:EEFT
|
US |
|
Bonduelle SA
F:BDU
|
FR |
|
Capgemini SE
PAR:CAP
|
FR |
|
C
|
Cencora Inc
F:ABG
|
US |
|
C
|
CleanTech Lithium PLC
OTC:CTLHF
|
JE |
|
V
|
Vestas Wind Systems A/S
F:VWSB
|
DK |
|
CEZ as
PSE:CEZ
|
CZ |
|
B
|
Bigcommerce Holdings Inc
F:BI1
|
US |
|
L
|
La-Z-Boy Inc
F:LAZ
|
US |
Shareholder Yield
Current shareholder yield for DMAA is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
DMAA Price
Drugs Made In America Acquisition Corp
| Average Annual Return | 4.93% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | 0% |
| Market Capitalization | 264.3m USD |
| Shares Outstanding | 24 280 000 |
| Percentage of Shares Shorted | 0.45% |
